Executive Editor
- Timothy Shipley, BioMed Central
Editorial Board | Editorial Team | Instructions for authors | FAQ
Articles
-
BMC Pulmonary Medicine 2011, 11:51Efficacy and safety of inhaled formoterol
Inhaled formoterol, a long-lasting beta2-agonist, is well tolerated in patients with chronic obstructive pulmonary disease and significantly increases lung function whilst reducing the need for patients to use reliever medication.
Hot topic
BMC Pulmonary Medicine 2011, 11:46 (30 September 2011)
Scope
BMC Pulmonary Medicine is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of pulmonary and associated disorders, as well as related molecular genetics, pathophysiology, and epidemiology.
From the blog
- 08 February 2012
- Invitation to submit to Cancer Bioinformatics thematic series
- 30 January 2012
- BMC-series journals on track for Impact Factor
- 18 January 2012
- Bacterial symbionts – the key to fighting pests and diseases?
Quote
"I strongly believe in the internet and open-access publishing in order to achieve scientific outreach both within academia and outside academia. Open-access allows anyone in the world with access to a computer to access scientific research. These innovative journals are becoming extremely successful and will change the nature of scientific publishing and increase the accessibility of science."
Professor Sally Blower
Semel Institute for Neuroscience & Human Behavior,
UCLA David Geffen School of Medicine, USA
Email alerts
Receive periodic news and updates relating to BioMed Central.
RSS
Comments
View more comments